These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3079408)

  • 21. Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death.
    Gieseler F; Nüssler V; Brieden T; Kunze J; Valsamas S
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):25-8. PubMed ID: 9476145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid.
    Niitsu N; Yamamoto-Yamaguchi Y; Kanatani Y; Shuto S; Matsuda A; Umeda M; Honma Y
    Exp Hematol; 1997 Nov; 25(12):1296-303. PubMed ID: 9357974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sugar-recognizing antibiotics, pradimicins].
    Oki T
    Tanpakushitsu Kakusan Koso; 1994 May; 39(6):973-8. PubMed ID: 8184107
    [No Abstract]   [Full Text] [Related]  

  • 24. Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation.
    Zhao YJ; Wei W; Su ZG; Ma GH
    Int J Pharm; 2009 Sep; 379(1):90-9. PubMed ID: 19540322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of action of a novel macromolecular antitumor antibiotic, SN-07, on mouse leukemia L1210 cells in culture.
    Yajima N; Miyata N; Kawanishi G; Katayama S; Tsukagoshi S
    Jpn J Cancer Res; 1987 Oct; 78(10):1121-7. PubMed ID: 3119545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of pharmacokinetic-pharmacodynamic relationships in the development of new anthracyclines.
    Robert J
    Cancer Chemother Pharmacol; 1993; 32(2):99-102. PubMed ID: 8485814
    [No Abstract]   [Full Text] [Related]  

  • 27. Infusional anthracyclines: is slower better? If so, why?
    Workman P
    Ann Oncol; 1992 Sep; 3(8):591-4. PubMed ID: 1450039
    [No Abstract]   [Full Text] [Related]  

  • 28. [Kinetics of the incorporation of anthracyclines in human lymphocytes].
    Frezard F; Tarasiuk Y; Garnier-Suillerot A
    Bull Cancer; 1989; 76(8):831-4. PubMed ID: 2620108
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical pharmacokinetics of doxorubicin.
    Speth PA; van Hoesel QG; Haanen C
    Clin Pharmacokinet; 1988 Jul; 15(1):15-31. PubMed ID: 3042244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer.
    Frassoldati A; Federico M; Barbieri F; Brausi M; Pollastri C; Berri G; Castagnetti G; Palladini PP; Silingardi V
    Med Oncol Tumor Pharmacother; 1991; 8(2):99-103. PubMed ID: 1749307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anthracyclines.
    Myers C
    Cancer Chemother Biol Response Modif; 1987; 9():36-49. PubMed ID: 3079408
    [No Abstract]   [Full Text] [Related]  

  • 32. Anthracyclines.
    Myers C
    Cancer Chemother Biol Response Modif; 1988; 10():33-9. PubMed ID: 3079388
    [No Abstract]   [Full Text] [Related]  

  • 33. Anthracyclines.
    Myers CE
    Cancer Chemother Biol Response Modif; 1992; 13():45-52. PubMed ID: 1389917
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
    Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synthesis and antiproliferative activity of a novel N-acyl derivative of doxorubicin].
    Shcherbakov VM; Devichenskiĭ VM; Vorontsov EA; Kuznetsov SL; Kriukov LN
    Bioorg Khim; 1999 Mar; 25(3):226-9. PubMed ID: 10382042
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.